Cover Image
Market Research Report
Product code 
936475

Europe Submental Fat Treatment Market - Industry Trends and Forecast to 2027

Published: | Data Bridge Market Research Private Limited | 120 Pages | Delivery time: Inquiry

Price

Back to Top
Europe Submental Fat Treatment Market - Industry Trends and Forecast to 2027
Published: April 1, 2020
Data Bridge Market Research Private Limited
Content info: 120 Pages
Delivery time: Inquiry
  • Description
  • Table of Contents
  • List of Tables

Europe submental fat treatment market is projected to register a CAGR of 12.8% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027

Market Segmentation

Europe Submental Fat Treatment Market, By Type (Invasive method and Minimally Invasive & Non Invasive Technology), End User (Cosmetic Centers, Hospitals, Dermatology Clinics, Medical Spa And Others), Distribution Channel (Direct Tender and Retail Sales Country (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest Of Europe) Industry Trends & Forecast to 2020

Some of the major factors contributing to the growth of the Europe submental fat treatment market are:

Increased demand for minimally invasive procedures

Availability of advanced and user friendly products

Market Players

The key market players for Europe submental fat treatment market are listed below:

12.8%

Allergan plc

Cynosure LLC

Candela Corporation

Alma Lasers

Cutera

Laser Lipo Ltd

ERCHONIA CORPORATION

ThermiGen LLC

Lumenis

HIRONIC CO. LTD.

INMODE

BTL group of Companies

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF EUROPE SUBMENTAL FAT TREATMENT MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 TYPE LIFELINE CURVE
  • 2.8 DBMR MARKET POSITION GRID
  • 2.9 MARKET APPLICATION COVERAGE GRID
  • 2.10 VENDOR SHARE ANALYSIS
  • 2.11 SECONDARY SOURCES
  • 2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 INDUSTRY INSIGHTS

  • 4.1 REIMBURSEMENT SCENARIO

5 MARKET OVERVIEW

  • 5.1 DRIVERS
    • 5.1.1 INCREASING AWARENESS FOR COSMETIC PROCEDURES AMONG PEOPLE
    • 5.1.2 RISING PREVALENCE OF OBESITY
    • 5.1.3 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES
    • 5.1.4 INCREASED RELIABILITY ON LIPOSUCTION PROCEDURE
    • 5.1.5 AVAILABILITY OF ADVANCED AND USER FRIENDLY PRODUCTS
  • 5.2 RESTRAINTS
    • 5.2.1 HIGH COST OF PROCEDURES
    • 5.2.2 INCREASED RISKS ASSOCIATED WITH THE PROCEDURES
    • 5.2.3 STRINGENT REGULATIONS FOR APPROVAL OF PRODUCTS
  • 5.3 OPPORTUNITIES
    • 5.3.1 EVOLUTION IN LASER AND RF DEVICES
    • 5.3.2 DECREASED DISPARITY BETWEEN MEN AND WOMEN FOR COSMETIC PROCEDURES
    • 5.3.3 INTRODUCTION OF NOVEL NON- INVASIVE TECHNOLOGY
  • 5.4 CHALLENGES
    • 5.4.1 INCREASED RECOVERY TIME OF PROCEDURES
    • 5.4.2 REQUIREMENT OF MULTIPLE SESSIONS FOR GETTING MAXIMUM RESULTS

6 EUROPE SUBMENTAL FAT TREATMENT MARKET, BY TYPE

  • 6.1 OVERVIEW
  • 6.2 MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY
    • 6.2.1 ULTRASOUND
    • 6.2.2 CRYOLIPOLYSIS
    • 6.2.3 RADIOFREQUENCY-ASSISTED CONTOURING
    • 6.2.4 LOW-LEVEL LASERS
    • 6.2.5 COMBINATION TREATMENT
    • 6.2.6 INJECTABLE ADIPOCYTOLYSIS
    • 6.2.7 OTHERS
  • 6.3 INVASIVE METHOD
    • 6.3.1 LIPOSUCTION
    • 6.3.2 SURGICAL REJUVENATION
    • 6.3.3 CHIN IMPLANT

7 EUROPE SUBMENTAL FAT TREATMENT MARKET, BY END USER

  • 7.1 OVERVIEW
  • 7.2 COSMETIC CENTERS
  • 7.3 HOSPITALS
  • 7.4 DERMATOLOGY CLINICS
  • 7.5 MEDICAL SPA
  • 7.6 OTHERS

8 EUROPE SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL

  • 8.1 OVERVIEW
  • 8.2 DIRECT TENDER
  • 8.3 RETAIL SALES

9 EUROPE SUBMENTAL FAT TREATMENT MARKET, BY GEOGRAPHY

  • 9.1 EUROPE
    • 9.1.1 GERMANY
    • 9.1.2 FRANCE
    • 9.1.3 ITALY
    • 9.1.4 U.K.
    • 9.1.5 SPAIN
    • 9.1.6 RUSSIA
    • 9.1.7 NETHERLANDS
    • 9.1.8 SWITZERLAND
    • 9.1.9 BELGIUM
    • 9.1.10 TURKEY
    • 9.1.11 REST OF EUROPE

10 EUROPE SUBMENTAL FAT TREATMENT MARKET, COMPANY LANDSCAPE

  • 10.1 COMPANY SHARE ANALYSIS: EUROPE

11 SWOT & DATA BRIDGE MARKET RESEARCH ANALYSIS

  • 11.1 SWOT ANALYSIS
    • 11.1.1 STRENGTH: - SIGNIFICANT GROWTH OF SHARES IN MARKET FOCUSED SEGMENT
    • 11.1.2 STRENGTH: - FOCUSED ON AESTHETIC SOLUTIONS
    • 11.1.3 WEAKNESS: DEPENDENCE ON SUPPLIERS/ DISTRIBUTORS
    • 11.1.4 OPPORTUNITY: - STRATEGIC INITIATIVES FOR BUSINESS EXPANISION BY PRODUCT LAUNCH, ACQUISITION AND OTHERS
    • 11.1.5 THREAT: - CURRENCY FLUCTUATION
  • 11.2 DATA BRIDGE MARKET RESEARCH ANALYSIS

12 COMPANY PROFILE

  • 12.1 ALLERGAN
    • 12.1.1 COMPANY SNAPSHOT
    • 12.1.2 REVENUE ANALYSIS
    • 12.1.3 COMPANY SHARE ANALYSIS
    • 12.1.4 PRODUCT PORTFOLIO
    • 12.1.5 RECENT DEVELOPMENTS
  • 12.2 INMODE
    • 12.2.1 COMPANY SNAPSHOT
    • 12.2.2 REVENUE ANALYSIS
    • 12.2.3 COMPANY SHARE ANALYSIS
    • 12.2.4 PRODUCT PORTFOLIO
    • 12.2.5 RECENT DEVELOPMENT
  • 12.3 HIRONIC CO., LTD.
    • 12.3.1 COMPANY SNAPSHOT
    • 12.3.2 REVENUE ANALYSIS
    • 12.3.3 COMPANY SHARE ANALYSIS
    • 12.3.4 PRODUCT PORTFOLIO
    • 12.3.5 RECENT DEVELOPMENT
  • 12.4 CANDELA CORPORATION
    • 12.4.1 COMPANY SNAPSHOT
    • 12.4.2 COMPANY SHARE ANALYSIS
    • 12.4.3 PRODUCT PORTFOLIO
    • 12.4.4 RECENT DEVELOPMENT
  • 12.5 CYNOSURE LLC
    • 12.5.1 COMPANY SNAPSHOT
    • 12.5.2 PRODUCT PORTFOLIO
    • 12.5.3 RECENT DEVELOPMENTS
  • 12.6 BTL GROUP OF COMPANIES
    • 12.6.1 COMPANY SNAPSHOT
    • 12.6.2 SOLUTION PORTFOLIO
    • 12.6.3 RECENT DEVELOPMENTS
  • 12.7 ALMA LASERS (A SUBSIDIARY OF SISRAM MEDICAL LTD)
    • 12.7.1 COMPANY SNAPSHOT
    • 12.7.2 REVENUE ANALYSIS
    • 12.7.3 PRODUCT PORTFOLIO
    • 12.7.4 RECENT DEVELOPMENTS
  • 12.8 ENDYMED MEDICAL
    • 12.8.1 COMPANY SNAPSHOT
    • 12.8.2 REVENUE ANALYSIS
    • 12.8.3 PRODUCT PORTFOLIO
    • 12.8.4 RECENT DEVELOPMENT
  • 12.9 CUTERA
    • 12.9.1 COMPANY SNAPSHOT
    • 12.9.2 REVENUE ANALYSIS
    • 12.9.3 PRODUCT PORTFOLIO
    • 12.9.4 RECENT DEVELOPMENT
  • 12.10 ALASTIN SKINCARE, INC.
    • 12.10.1 COMPANY SNAPSHOT
    • 12.10.2 PRODUCT PORTFOLIO
    • 12.10.3 RECENT DEVELOPMENTS
  • 12.11 ERCHONIA CORPORATION
    • 12.11.1 COMPANY SNAPSHOT
    • 12.11.2 PRODUCT PORTFOLIO
    • 12.11.3 RECENT DEVELOPMENT
  • 12.12 LASER LIPO LTD.
    • 12.12.1 COMPANY SNAPSHOT
    • 12.12.2 PRODUCT PORTFOLIO
    • 12.12.3 RECENT DEVELOPMENT
  • 12.13 LUMENIS
    • 12.13.1 COMPANY SNAPSHOT
    • 12.13.2 PRODUCT PORTFOLIO
    • 12.13.3 RECENT DEVELOPMENT
  • 12.14 SOLTA MEDICAL
    • 12.14.1 COMPANY SNAPSHOT
    • 12.14.2 BRAND PORTFOLIO
    • 12.14.3 RECENT DEVELOPMENT
  • 12.15 THERMIGEN, LLC.
    • 12.15.1 COMPANY SNAPSHOT
    • 12.15.2 PRODUCT PORTFOLIO
    • 12.15.3 RECENT DEVELOPMENT

13 QUESTIONNAIRE

14 CONCLUSION

15 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 NUMBER OF SURGICAL AND NON SURGICAL AESTHETIC PROCEDURES IN DIFFERENT COUNTRIES
  • TABLE 2 AVERAGE COST OF LIPOSUCTION ACROSS THE U.S.
  • TABLE 3 AVERAGE COSTS OF CHIN AUGMENTATION ACROSS THE U.S.
  • TABLE 4 EUROPE SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 5 EUROPE MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 6 EUROPE MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 7 EUROPE INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8 EUROPE INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 9 EUROPE SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 10 EUROPE COSMETIC CENTERS IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 11 EUROPE HOSPITALS IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 12 EUROPE DERMATOLOGY CLINICS IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 13 EUROPE MEDICAL SPA IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 14 EUROPE OTHERS IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 15 EUROPE SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 16 EUROPE DIRECT TENDER IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17 EUROPE RETAIL SALES IN SUBMENTAL FAT TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 18 EUROPE SUBMENTAL FAT TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 19 EUROPE SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 20 EUROPE MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 21 EUROPE INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 22 EUROPE SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 23 EUROPE SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 24 GERMANY SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 25 GERMANY MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 26 GERMANY INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 27 GERMANY SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 28 GERMANY SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 29 FRANCE SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 30 FRANCE MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 31 FRANCE INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 32 FRANCE SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 33 FRANCE SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 34 ITALY SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 35 ITALY MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 36 ITALY INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 37 ITALY SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 38 ITALY SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 39 U.K. SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 40 U.K. MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 41 U.K. INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 42 U.K. SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 43 U.K. SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 44 SPAIN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 45 SPAIN MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 46 SPAIN INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 47 SPAIN SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 48 SPAIN SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 49 RUSSIA SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 50 RUSSIA MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 51 RUSSIA INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 52 RUSSIA SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 53 RUSSIA SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 54 NETHERLANDS SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 55 NETHERLANDS MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 56 NETHERLANDS INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 57 NETHERLANDS SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 58 NETHERLANDS SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 59 SWITZERLAND SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 60 SWITZERLAND MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 61 SWITZERLAND INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 62 SWITZERLAND SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 63 SWITZERLAND SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 64 BELGIUM SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 65 BELGIUM MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 66 BELGIUM INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 67 BELGIUM SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 68 BELGIUM SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 69 TURKEY SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 70 TURKEY MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 71 TURKEY INVASIVE METHOD IN SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)
  • TABLE 72 TURKEY SUBMENTAL FAT TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 73 TURKEY SUBMENTAL FAT TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 74 REST OF EUROPE SUBMENTAL FAT TREATMENT MARKET, BY TYPE, 2018-2027 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 EUROPE SUBMENTAL FAT TREATMENT MARKET: SEGMENTATION
  • FIGURE 2 EUROPE SUBMENTAL FAT TREATMENT MARKET: DATA TRIANGULATION
  • FIGURE 3 EUROPE SUBMENTAL FAT TREATMENT MARKET: DROC ANALYSIS
  • FIGURE 4 EUROPE SUBMENTAL FAT TREATMENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 EUROPE SUBMENTAL FAT TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 EUROPE SUBMENTAL FAT TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 EUROPE SUBMENTAL FAT TREATMENTMARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 EUROPE SUBMENTAL FAT TREATMENT MARKET: MARKET APPLICATION COVERAGE GRID
  • FIGURE 9 EUROPE SUBMENTAL FAT TREATMENT MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 10 EUROPE SUBMENTAL FAT TREATMENT MARKET: SEGMENTATION
  • FIGURE 11 GROWING FOCUS ON AESTHETICS AND EXPANSION OF TARGET DEMOGRAPHICS ARE EXPECTED TO DRIVE THE EUROPE SUBMENTAL FAT TREATMENT MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 12 MINIMALLY INVASIVE & NON-INVASIVE TECHNOLOGY IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE SUBMENTAL FAT TREATMENT MARKET IN 2020 & 2027
  • FIGURE 13 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGES OF EUROPE SUBMENTAL FAT TREATMENT MARKET
  • FIGURE 14 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY TYPE, 2019
  • FIGURE 15 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY TYPE, 2019-2027 (USD MILLION)
  • FIGURE 16 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY TYPE, CAGR (2020-2027)
  • FIGURE 17 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY TYPE, LIFELINE CURVE
  • FIGURE 18 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY END USER, 2019
  • FIGURE 19 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY END USER, 2019-2027 (USD MILLION)
  • FIGURE 20 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY END USER, CAGR (2020-2027)
  • FIGURE 21 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 22 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2019
  • FIGURE 23 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
  • FIGURE 24 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027)
  • FIGURE 25 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 26 EUROPE SUBMENTAL FAT TREATMENT MARKET: SNAPSHOT (2019)
  • FIGURE 27 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019)
  • FIGURE 28 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 29 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 30 EUROPE SUBMENTAL FAT TREATMENT MARKET: BY TYPE (2020-2027)
  • FIGURE 31 EUROPE SUBMENTAL FAT TREATMENT MARKET: COMPANY SHARE 2019 (%)